Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage.
Calcitonin gene-related peptide is a potent vasodilator neuropeptide that is localized in perivascular sensory nerves. To determine whether alpha-calcitonin gene-related peptide possesses protective activity against hypertension-induced end organ damage, hypertension was induced in alpha-calcitonin gene-related/calcitonin peptide knockout and wild-type mice by uninephrectomy, deoxycorticosteroid administration, and 0.9% saline drinking water. These mice were instrumented previously for long-term telemetric blood pressure recording. Control groups were sham-operated and given tap water. Mean arterial pressures were determined, and 3 weeks after initiation of each protocol, tissues were taken for histopathologic studies. The deoxycorticosteroid-salt protocol produced a significant 35% mean arterial pressure increase in both mouse strains. No pathological changes were observed in sections of aortas and femoral arteries from any of the groups studied. Likewise, heart and kidney sections from the hypertensive wild-type mice showed no pathological changes compared with their normotensive counterparts. In contrast, marked vasculitis was seen in the heart sections from the deoxycorticosteroid-salt-treated alpha-calcitonin gene-related peptide knockout mice with thickening and inflammation of the vessel walls. In addition, myocarditis and focal epicarditis with areas of myocardial necrosis were present. Kidneys of these mice exhibited prominent glomerular changes including congestion of the capillary loops, focal mesangial and crescent proliferation, and focal histocytic infiltration. Urinary microalbumin was significantly higher in the hypertensive alpha-calcitonin gene-related peptide knockout compared with hypertensive wild-type mice. These data suggest that deletion of the alpha-calcitonin gene-related peptide gene makes the heart and kidneys more vulnerable to hypertension-induced end organ damage.
Supowit
Scott C
SC
Texas A&M University System Health Science Center, Temple, TX, USA. ssupowit@swmail.sw.org
Rao
Arundhati
A
Bowers
Mark C
MC
Zhao
Huawei
H
Fink
Gregory
G
Steficek
Barbara
B
Patel
Parag
P
Katki
Khurshed A
KA
Dipette
Donald J
DJ
D000419:Albuminuria / Q000209:etiology / Q000517:prevention & control; D000818:Animals; D001011:Aorta / Q000473:pathology; D001794:Blood Pressure / Q000235:genetics / Q000502:physiology; D015740:Calcitonin Gene-Related Peptide / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D002196:Capillaries / Q000473:pathology; D003327:Coronary Disease / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D003900:Desoxycorticosterone / Q000633:toxicity; D005263:Femoral Artery / Q000473:pathology; D005920:Glomerular Mesangium / Q000473:pathology; D006973:Hypertension / Q000150:complications* / Q000235:genetics; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009205:Myocarditis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D032383:Myocytes, Cardiac / Q000473:pathology; D009392:Nephrectomy; D009929:Organ Size / Q000187:drug effects; D017673:Sodium Chloride, Dietary / Q000633:toxicity; D013686:Telemetry; D014657:Vasculitis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*
D017673:Sodium Chloride, Dietary; D003900:Desoxycorticosterone; D015740:Calcitonin Gene-Related Peptide